ClinConnect ClinConnect Logo
Search / Trial NCT00599898

Nifedipine Compared to Atosiban for Treating Preterm Labor

Launched by RAED SALIM · Jan 13, 2008

Trial Information

Current as of May 07, 2025

Completed

Keywords

Preterm Labor Atosiban Nifedipine

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Gestational age between 24 to 34 weeks which had been documented by a definite LMP and sonography up to 20 weeks.
  • 2. All women fulfilled the criteria of preterm labor. The diagnosis of preterm labor required the presence of 4 uterine contractions or more over 30 minutes, each lasting at least 30 seconds, and documented cervical change. The cervical criteria were met when either of the following was present:
  • 1. Nulliparous women: a single cervical examination demonstrating dilatation of 0 cm to 4 cm and effacement of at least 50%
  • 2. Multiparous women: a single cervical examination demonstrating dilatation of 1 cm to 4 cm and effacement of at least 50%.
  • 3. Provision of written informed consent
  • Exclusion Criteria:
  • 1. Chorioamnionitis
  • 2. Preterm rupture of membranes
  • 3. Vaginal bleeding
  • 4. Major fetal malformations
  • 5. Severe hypertensive disorders
  • 6. Intrauterine growth restriction (\< 5th percentile).
  • 7. Non-reassuring fetal heart rate
  • 8. Maternal contraindications
  • 1. Chronic hypertension
  • 2. Systolic blood pressure \< 90 mmHg
  • 3. Cardiovascular disease
  • 4. Elevated hepatic enzymes
  • 9. Congenital or acquired uterine malformation

About Raed Salim

Raed Salim is a distinguished clinical trial sponsor recognized for its commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and cutting-edge methodologies, Raed Salim collaborates with leading healthcare institutions and researchers to design and implement rigorous clinical trials. The organization prioritizes ethical standards and regulatory compliance, ensuring the safety and well-being of participants while striving to bring new treatments to market efficiently. Through its dedication to scientific excellence and patient-centric approaches, Raed Salim plays a pivotal role in the development of transformative healthcare solutions.

Locations

Afula, , Israel

Afula, , Israel

Patients applied

0 patients applied

Trial Officials

Gali Garmi, MD

Principal Investigator

HaEmek Medical Center, Afula, Israel

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials